profusa.com - רווח החברה לפני מסים, ריבית ופחת PFSA

Profusa Inc generates revenue from the supply of biosensors, where the regular replacement of sensors ensures a stable cash flow. The current EBITDA_Co level correlates with these volumes, with 0.00 representing the current level of the indicator. Business efficiency relies on complex medical distribution of devices. The team's ultimate success depends on passing clinical trials and obtaining official regulatory approvals.

This indicator serves as a critical filter during asset stress testing, allowing for an assessment of the business's actual ability to generate cash flow before interest and amortization. By analyzing absolute EBITDA, the investor sees the net result of the operating activities of Profusa Inc. (PFSA), where the stability of the chart confirms the independence of medical innovations from market cycles and progress in the commercialization of developments.